Hypertension Theraphy

Arriva therapy for resistant hypertension unresponsive to medication. It is a biotech therapy, the ‘Rheos Baroreflex Activation Therapy’ (BAT), which give ‘on those who suffer from this disorder higher quality’ and life expectancy. The first patients to benefit will be those of Lombardy, Tuscany and Emilia Romagna, but by the end of 2010, will be ‘extended to other regions and in Europe.

“The purpose of the Bat – said prof. Gianfranco Parati, head of cardiology Auxologico Institute, Milan – via a pacemaker is electrically stimulate the carotid baroreceptors, and that is one of the most important mechanisms involved in regulating blood pressure. Their stimulation reduces sympathetic nerve activity and leads to vasodilation and slow heart rate, and consequently a reduction in blood pressure.